Brief: Surface Oncology Reports Q4 Earnings Per Share $1.56
09/03/2021 15:04
March 9 (Reuters) - Surface Oncology Inc SURF.O :
* SURFACE ONCOLOGY REPORTS FINANCIAL RESULTS AND CORPORATE
HIGHLIGHTS FOR FOURTH QUARTER AND FULL YEAR 2020
* Q4 EARNINGS PER SHARE $1.56
* Q4 EARNINGS PER SHARE ESTIMATE $-0.05 -- REFINITIV IBES
DATA
* Q4 REVENUE $87.6 MILLION VERSUS $1.0 MILLION
* Q4 REVENUE ESTIMATE $17 MILLION -- REFINITIV IBES DATA
* CONTINUES TO PROJECT CASH RUNWAY SUFFICIENT THROUGH 2023
* NEW COLLABORATION WITH MERCK WILL EVALUATE SRF388,
TARGETING
IL-27, IN COMBINATION WITH KEYTRUDA IN PATIENTS WITH SOLID
TUMORS
* INVESTIGATIONAL NEW DRUG (IND) FILING FOR SRF813
ANTICIPATED IN
2021
Source text for Eikon: ID:nGNX3kXFNL
Further company coverage: SURF.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Surface Oncology
See all newsBrief: Surface Oncology Says Anticipates Will Have Net Cash Of $20 Million To $25 Million At The Closing Of The Proposed Mergers
Surface Oncology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Surface Oncology, Inc. Q2 Net Income USD -28.2 Mln
Surface Oncology Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: ADAR1 Partners Reports 5.24% Passive Stake In Surface Oncology Inc As Of July 10 - SEC Filing